Year |
Citation |
Score |
2023 |
Malta TM, Sabedot TS, Morosini NS, Datta I, Garofano L, Vallentgoed WR, Varn FS, Aldape K, D'Angelo F, Bakas S, Barnholtz-Sloan JS, Gan HK, Hasanain M, Hau AC, Johnson KC, ... ... Noushmehr H, et al. The epigenetic evolution of glioma is determined by the IDH1 mutation status and treatment regimen. Cancer Research. PMID 38117484 DOI: 10.1158/0008-5472.CAN-23-2093 |
0.395 |
|
2023 |
Gielniewski B, Poleszak K, Roura AJ, Szadkowska P, Jacek K, Krol SK, Guzik R, Wiechecka P, Maleszewska M, Kaza B, Marchel A, Czernicki T, Koziarski A, Zielinski G, Styk A, ... ... Noushmehr H, et al. Targeted sequencing of cancer-related genes reveals a recurrent TOP2A variant which affects DNA binding and coincides with global transcriptional changes in glioblastoma. International Journal of Cancer. PMID 37338006 DOI: 10.1002/ijc.34631 |
0.331 |
|
2022 |
Varn FS, Johnson KC, Martinek J, Huse JT, Nasrallah MP, Wesseling P, Cooper LAD, Malta TM, Wade TE, Sabedot TS, Brat D, Gould PV, Wöehrer A, Aldape K, Ismail A, ... ... Noushmehr H, et al. Glioma progression is shaped by genetic evolution and microenvironment interactions. Cell. PMID 35649412 DOI: 10.1016/j.cell.2022.04.038 |
0.31 |
|
2022 |
Herrgott GA, Asmaro KP, Wells M, Sabedot TS, Malta TM, Mosella MS, Nelson K, Scarpace L, Barnholtz-Sloan JS, Sloan AE, Selman WR, deCarvalho AC, Poisson LM, Mukherjee A, Robin AM, ... ... Noushmehr H, et al. Detection of Tumor-specific DNA Methylation Markers in the Blood of Patients with Pituitary Neuroendocrine Tumors. Neuro-Oncology. PMID 35212383 DOI: 10.1093/neuonc/noac050 |
0.337 |
|
2021 |
Mosella MS, Sabedot TS, Silva TC, Malta TM, Segato FD, Asmaro KP, Wells M, Mukherjee A, Poisson LM, Snyder J, deCarvalho AC, Walbert T, Aho T, Steven K, Elias PC, ... ... Noushmehr H, et al. DNA Methylation-based Signatures Classify Sporadic Pituitary Tumors According to Clinicopathological Features. Neuro-Oncology. PMID 33631002 DOI: 10.1093/neuonc/noab044 |
0.355 |
|
2021 |
Sabedot T, Malta T, Snyder J, Nelson K, Wells M, deCarvalho A, Mukherjee A, Chitale D, Mosella M, Sokolov A, Asmaro K, Robin A, Rosenblum M, Mikkelsen T, Rock J, ... ... Noushmehr H, et al. A serum-based DNA methylation assay provides accurate detection of glioma. Neuro-Oncology. PMID 33560371 DOI: 10.1093/neuonc/noab023 |
0.318 |
|
2020 |
Chen J, Mitra A, Li S, Song S, Nguyen BN, Chen JS, Shin JH, Gough NR, Lin P, Obias V, He AR, Yao Z, Malta TM, Noushmehr H, Latham PS, et al. Targeting the E3 Ubiquitin Ligase PJA1 Enhances Tumor-Suppressing TGF-β Signaling. Cancer Research. PMID 32127355 DOI: 10.1158/0008-5472.Can-19-3116 |
0.314 |
|
2020 |
Colaprico A, Olsen C, Bailey MH, Odom GJ, Terkelsen T, Silva TC, Olsen AV, Cantini L, Zinovyev A, Barillot E, Noushmehr H, Bertoli G, Castiglioni I, Cava C, Bontempi G, et al. Interpreting pathways to discover cancer driver genes with Moonlight. Nature Communications. 11: 69. PMID 31900418 DOI: 10.1038/S41467-019-13803-0 |
0.463 |
|
2020 |
Wells M, Asmaro KP, Sabedot TS, Mosella MS, Malta, PharmD TM, Nelson K, Snyder J, deCarvalho A, Mukherjee A, Chitale D, Robin A, Rosenblum ML, Mikkelsen T, Poisson L, ... ... Noushmehr H, et al. OR32-03 Serum Cell-Free Methylation-Based Signatures Distinguishes Pituitary Tumors According to Functional Status and from Other Neoplasia: A Liquid Biopsy Approach Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.542 |
0.428 |
|
2020 |
Wells M, Asmaro K, Rock J, Sabedot T, Mosella M, Malta T, Nelson K, Snyder J, Kalkanis S, Castro AV, Noushmehr H. Abstract A11: Serum cell-free DNA methylome-based signatures distinguish pituitary tumor from other neoplasias and by clinicopathologic features Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Liqbiop20-A11 |
0.41 |
|
2020 |
Sabedot T, Malta T, Snyder J, Nelson K, Wells M, deCarvalho A, Mukherjee A, Chitale D, Mosella M, Asmaro K, Robin A, Rosenblum M, Mikkelsen T, Rock J, Poisson L, ... ... Noushmehr H, et al. Abstract A10: Glioma cell-free DNA methylation marker for diagnosis and monitoring Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Liqbiop20-A10 |
0.488 |
|
2020 |
Lin X, Spindler TJ, Fonseca MAdS, Corona RI, Seo J, Dezem FS, Li L, Lee JM, Long HW, Sellers TA, Karlan BY, Noushmehr H, Freedman ML, Gayther SA, Lawrenson K. Abstract A30: Super-enhancer-associated long noncoding RNA UCA1 interacts directly with AMOT to inhibit Hippo signaling pathway in epithelial ovarian cancer Molecular Cancer Research. 18. DOI: 10.1158/1557-3125.Hippo19-A30 |
0.307 |
|
2020 |
Sabedot TS, Malta TM, She R, Snyder J, Walbert T, Lee I, Kalkanis S, Ewing J, Castro A, Noushmehr H. Abstract 781: Methylation-based liquid biopsy of meningioma primary and recurrent samples Cancer Research. 80: 781-781. DOI: 10.1158/1538-7445.Am2020-781 |
0.479 |
|
2019 |
Lawrenson K, Fonseca MAS, Liu AY, Segato Dezem F, Lee JM, Lin X, Corona RI, Abbasi F, Vavra KC, Dinh HQ, Gill NK, Seo JH, Coetzee S, Lin YG, Pejovic T, ... ... Noushmehr H, et al. A Study of High-Grade Serous Ovarian Cancer Origins Implicates the SOX18 Transcription Factor in Tumor Development. Cell Reports. 29: 3726-3735.e4. PMID 31825847 DOI: 10.1016/J.Celrep.2019.10.122 |
0.409 |
|
2019 |
Barthel FP, Johnson KC, Varn FS, Moskalik AD, Tanner G, Kocakavuk E, Anderson KJ, Abiola O, Aldape K, Alfaro KD, Alpar D, Amin SB, Ashley DM, Bandopadhayay P, Barnholtz-Sloan JS, ... ... Noushmehr H, et al. Longitudinal molecular trajectories of diffuse glioma in adults. Nature. PMID 31748746 DOI: 10.1038/S41586-019-1775-1 |
0.377 |
|
2019 |
Victor RR, Malta TM, Seki T, Lita A, Dowdy T, Celiku O, Cavazos-Saldana A, Li A, Liu Y, Han S, Zhang W, Song H, Davis D, Lee S, Trepel JB, ... ... Noushmehr H, et al. Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas. Neuro-Oncology. PMID 31665443 DOI: 10.1093/Neuonc/Noz207 |
0.37 |
|
2019 |
Lin X, Spindler TJ, de Souza Fonseca MA, Corona RI, Seo JH, Dezem FS, Li L, Lee JM, Long HW, Sellers TA, Karlan BY, Noushmehr H, Freedman ML, Gayther SA, Lawrenson K. Super-Enhancer-Associated LncRNA UCA1 Interacts Directly with AMOT to Activate YAP Target Genes in Epithelial Ovarian Cancer. Iscience. 17: 242-255. PMID 31307004 DOI: 10.1016/J.Isci.2019.06.025 |
0.35 |
|
2019 |
Nassiri F, Mamatjan Y, Suppiah S, Badhiwala JH, Mansouri S, Karimi S, Saarela O, Poisson L, Gepfner-Tuma I, Schittenhelm J, Ng HK, Noushmehr H, Harter P, Baumgarten P, Weller M, et al. DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical management. Neuro-Oncology. PMID 31158293 DOI: 10.1093/Neuonc/Noz061 |
0.336 |
|
2019 |
Gusev A, Lawrenson K, Lin X, Lyra PC, Kar S, Vavra KC, Segato F, Fonseca MAS, Lee JM, Pejovic T, Liu G, Karlan BY, Freedman ML, Noushmehr H, et al. A transcriptome-wide association study of high-grade serous epithelial ovarian cancer identifies new susceptibility genes and splice variants. Nature Genetics. PMID 31043753 DOI: 10.1038/S41588-019-0395-X |
0.411 |
|
2019 |
Lawrenson K, Song F, Hazelett DJ, Kar SP, Tyrer J, Phelan CM, Corona RI, Rodríguez-Malavé NI, Seo JH, Adler E, Coetzee SG, Segato F, Fonseca MAS, Amos CI, Carney ME, ... ... Noushmehr H, et al. Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women. Gynecologic Oncology. PMID 30898391 DOI: 10.1016/J.Ygyno.2019.02.023 |
0.366 |
|
2019 |
Mounir M, Lucchetta M, Silva TC, Olsen C, Bontempi G, Chen X, Noushmehr H, Colaprico A, Papaleo E. New functionalities in the TCGAbiolinks package for the study and integration of cancer data from GDC and GTEx. Plos Computational Biology. 15: e1006701. PMID 30835723 DOI: 10.1371/Journal.Pcbi.1006701 |
0.412 |
|
2019 |
Snyder J, Poisson LM, Noushmehr H, Castro AV, de Carvalho AC, Robin A, Mukherjee A, Lee I, Walbert T. Clinical and research applications of a brain tumor tissue bank in the age of precision medicine. Personalized Medicine. PMID 30816054 DOI: 10.2217/Pme-2018-0102 |
0.367 |
|
2019 |
Suppiah S, Nassiri F, Bi WL, Dunn IF, Hanemann CO, Horbinski CM, Hashizume R, James CD, Mawrin C, Noushmehr H, Perry A, Sahm F, Sloan A, Von Deimling A, Wen PY, et al. Molecular and translational advances in meningiomas. Neuro-Oncology. 21: i4-i17. PMID 30649490 DOI: 10.1093/Neuonc/Noy178 |
0.381 |
|
2019 |
Mosella M, Sabedot T, Malta T, Felicella M, Aho T, Poisson L, deCarvalho A, Noushmehr H, Rock J, Castro AV. OR24-5 Aberrant DNA Methylation in Regulatory Genomic Elements Are Associated with Invasive Behavior of Pituitary Macroadenomas: An Integrative Analysis of Epigenome-Wide Studies Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Or24-5 |
0.41 |
|
2019 |
Sabedot TS, Cassel SH, Gao GF, Lareau CA, Cherniack A, Lazar A, Kadoch C, Noushmehr H. Abstract 907: Bioinformatic method to define epigenetically regulated enhancer elements associated with cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-907 |
0.35 |
|
2019 |
Malta TM, Snyder J, Wells M, deCarvalho A, Poisson L, Souza C, Zadeh G, Aldape K, Tirapelli D, Carlotti C, Lee Y, Kalkanis S, Walbert T, Noushmehr H. Abstract 841: Meningioma subgroups associated with functional genomic elements defined by DNA methylation Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-841 |
0.415 |
|
2019 |
Abraham BJ, Reddy J, Fonseca MA, Klein IA, Afeyan LK, Corona RI, Cejas P, Segato F, Karlan BY, Gayther SA, Freedman ML, Noushmehr H, Brown M, Matulonis UA, Lawrenson K, et al. Abstract 2615: Systematic approaches to predict oncogenic transcriptional regulatory circuitries identify important nodes in high-grade serous ovarian cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-2615 |
0.33 |
|
2019 |
Davoodi-Bojd E, Malta T, Griffith B, Snyder J, Walbert T, Noushmehr H, Soltanian-Zadeh H. Abstract 1939: Non-invasive prediction of glioma tumor stemness using multimodal MRI Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-1939 |
0.338 |
|
2019 |
Noushmehr H, Sabedot TS, Malta TM, Nelson KK, Snyder J, Wells M, Mosella MS, deCarvalho AC, Asmaro K, Scarpace L, Robin AM, Rosenblum ML, Mikkelsen T, Rock J, Walbert T, et al. Abstract LB-234: Pre-surgical identification of diagnostic, prognostic and predictive DNA methylation-based markers in serum (liquid biopsy) of patients harboring gliomas Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-234 |
0.498 |
|
2019 |
Wells M, Sabedot T, Malta T, Snyder J, Poisson L, Noushmehr H. Abstract 1640: Deep learning classification of neuro-oncology medical documents Cancer Research. 79: 1640-1640. DOI: 10.1158/1538-7445.Am2019-1640 |
0.332 |
|
2019 |
Lee IY, Sabedot T, Malta T, Snyder J, Wells M, DeCarvalho A, Mukherjee A, Chitale D, Asmaro KP, Robin AM, Rosenblum ML, Mikkelsen T, Rock JP, Poisson L, Walbert T, ... ... Noushmehr H, et al. Detection of Glioma and Prognostic Subtypes by Noninvasive Circulating Cell-Free DNA Methylation Markers Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_630 |
0.465 |
|
2019 |
Asmaro KP, Mosella MS, Wells M, Sabedot T, Malta T, Nelson K, Snyder J, DeCarvalho A, Mukherjee A, Chitale D, Aho T, Robin AM, Rosenblum ML, Mikkelsen T, Poisson L, ... ... Noushmehr H, et al. Candidate Regulatory Elements in Coding and Noncoding Regions are Associated With Invasive Behavior in Pituitary Tumors Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_157 |
0.459 |
|
2019 |
Sabedot TS, Malta T, Snyder J, Walbert T, Lee I, Kalkanis S, Castro A, Noushmehr H. Gene-61. Methylation-Based Liquid Biopsy Of Meningioma Primary And Recurrent Samples Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.463 |
0.326 |
|
2019 |
Berezovsky A, Nuga O, Meng Y, Poisson L, Noushmehr H, deCarvalho A. GENE-55. GENE EXPRESSION SIGNATURE ASSOCIATED WITH AGGRESSIVE GLIOBLASTOMA GROWTH IS ENRICHED IN CHROMATIN MODIFICATION AND STEMNESS TRANSCRIPTIONAL REGULATION PROGRAMS Neuro-Oncology. 21: vi109-vi109. DOI: 10.1093/Neuonc/Noz175.457 |
0.448 |
|
2019 |
Wells M, Sabedot TS, Asmaro K, Mosella M, Malta T, Nelson K, Snyder J, deCarvalho A, Mukherjee A, Bahn A, Robin A, Rosenblum M, Mikkelsen T, Poisson L, Lee I, ... ... Noushmehr H, et al. Gene-24. Dna Methylation Signatures Detected In A Serum-Based Liquid Biopsy Distinguish Functional And Invasiveness Features In Pituitary Adenomas Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.426 |
0.371 |
|
2019 |
Ng HK, Li KK, Malta TM, Shi Z, Noushmehr H. Combined epigenetic signature and gene copy number variations in IDH-mutant glioblastomas showed varied risk stratification Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz167.006 |
0.324 |
|
2019 |
Li KK, Chen H, Noushmehr H, Ng H. Path-15. Identification Of Subsets Of Idh-Mutant Glioblastomas With Distinct Epigenetic And Copy Number Alterations And Stratified Clinical Risks Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz126.283 |
0.316 |
|
2019 |
Mosella MQS, Sabedot TS, Malta TM, Rock J, Felicella M, Aho T, Noushmehr H, Castro AV. P13.15 DNA methylation abnormalities in non-promoter regulatory regions are associated with invasive behavior in pituitary tumors Neuro-Oncology. 21: iii65-iii66. DOI: 10.1093/Neuonc/Noz126.236 |
0.462 |
|
2019 |
Castro AV, Wells M, Asmaro K, Sabedot TS, Mosella MS, Malta TM, Nelson K, Snyder J, deCarvalho A, Mukherjee A, Chitale D, Robin A, Rosenblum M, Mikkelsen T, Poisson LM, ... ... Noushmehr H, et al. P01.02 Serum-derived DNA methylation markers distinguish functional and invasiveness subtypes in patients harboring pituitary tumors Neuro-Oncology. 21: iii24-iii24. DOI: 10.1093/Neuonc/Noz126.080 |
0.442 |
|
2019 |
Noushmehr H, Sabedot T, Malta T, Nelson K, Snyder J, Wells M, deCarvalho A, Mukherjee A, Chitale D, Mosella M, Asmaro K, Robin A, Rosenblum M, Mikkelsen T, Rock J, et al. OS1.5 Detection of glioma and prognostic subtypes by non-invasive circulating cell-free DNA methylation markers Neuro-Oncology. 21: iii6-iii6. DOI: 10.1093/Neuonc/Noz126.018 |
0.465 |
|
2018 |
Buckley MA, Woods NT, Tyrer JP, Mendoza-Fandiño G, Lawrenson K, Hazelett DJ, Najafabadi HS, Gjyshi A, Carvalho RS, Lyra PC, Coetzee SG, Shen HC, Yang AW, Earp MA, Yoder S, ... ... Noushmehr H, et al. Functional analysis and fine mapping of the 9p22.2 ovarian cancer susceptibility locus. Cancer Research. PMID 30487138 DOI: 10.1158/0008-5472.Can-17-3864 |
0.409 |
|
2018 |
Silva TC, Coetzee SG, Gull N, Yao L, Hazelett DJ, Noushmehr H, Lin DC, Berman BP. ELMER v.2: An R/Bioconductor package to reconstruct gene regulatory networks from DNA methylation and transcriptome profiles. Bioinformatics (Oxford, England). PMID 30364927 DOI: 10.1093/Bioinformatics/Bty902 |
0.407 |
|
2018 |
de Souza CF, Sabedot TS, Malta TM, Stetson L, Morozova O, Sokolov A, Laird PW, Wiznerowicz M, Iavarone A, Snyder J, deCarvalho A, Sanborn Z, McDonald KL, Friedman WA, Tirapelli D, ... ... Noushmehr H, et al. A Distinct DNA Methylation Shift in a Subset of Glioma CpG Island Methylator Phenotypes during Tumor Recurrence. Cell Reports. 23: 637-651. PMID 29642018 DOI: 10.1016/J.Celrep.2018.03.107 |
0.627 |
|
2018 |
Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, ... ... Noushmehr H, et al. The Immune Landscape of Cancer. Immunity. PMID 29628290 DOI: 10.1016/J.Immuni.2018.03.023 |
0.406 |
|
2018 |
Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, Kamińska B, Huelsken J, Omberg L, Gevaert O, Colaprico A, Czerwińska P, Mazurek S, Mishra L, Heyn H, ... ... Noushmehr H, et al. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell. 173: 338-354.e15. PMID 29625051 DOI: 10.1016/J.Cell.2018.03.034 |
0.586 |
|
2018 |
Hoadley KA, Yau C, Hinoue T, Wolf DM, Lazar AJ, Drill E, Shen R, Taylor AM, Cherniack AD, Thorsson V, Akbani R, Bowlby R, Wong CK, Wiznerowicz M, Sanchez-Vega F, ... ... Noushmehr H, et al. Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer. Cell. 173: 291-304.e6. PMID 29625048 DOI: 10.1016/J.Cell.2018.03.022 |
0.726 |
|
2018 |
Aldape K, Amin SB, Ashley DM, Barnholtz-Sloan JS, Bates AJ, Beroukhim R, Bock C, Brat DJ, Claus EB, Costello JF, de Groot JF, Finocchiaro G, French PJ, Gan HK, Griffith B, ... ... Noushmehr H, et al. Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium. Neuro-Oncology. PMID 29432615 DOI: 10.1093/Neuonc/Noy020 |
0.396 |
|
2018 |
Mall R, Cerulo L, Garofano L, Frattini V, Kunji K, Bensmail H, Sabedot TS, Noushmehr H, Lasorella A, Iavarone A, Ceccarelli M. RGBM: regularized gradient boosting machines for identification of the transcriptional regulators of discrete glioma subtypes. Nucleic Acids Research. PMID 29361062 DOI: 10.1093/Nar/Gky015 |
0.332 |
|
2018 |
Snyder J, Malta TM, Noushmehr H. IDO1 expression in glioma molecular subtypes. Journal of Clinical Oncology. 36: e14029-e14029. DOI: 10.1200/Jco.2018.36.15_Suppl.E14029 |
0.354 |
|
2018 |
Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein J, Kamińska B, Huelsken J, Omberg L, Gevaert O, Colaprico A, Czerwińska P, Mazurek S, Mishra L, Heyn H, ... ... Noushmehr H, et al. Abstract LB-373: Comprehensive analysis of cancer stemness Cancer Research. 78. DOI: 10.1158/1538-7445.Am2018-Lb-373 |
0.609 |
|
2018 |
Liu AY, Vavra KC, Corona RI, Abassi F, Fonseca M, Segato F, Freedman ML, Gayther SA, Noushmehr H, Lawrenson K. Abstract 1494: SOX18: A novel master regulator of high-grade serous ovarian tumorigenesis Cancer Research. 78: 1494-1494. DOI: 10.1158/1538-7445.Am2018-1494 |
0.486 |
|
2018 |
Sabedot T, deCarvalho A, Poisson L, Snyder J, Walbert T, Lee I, Kalkanis S, Berman B, Noushmehr H. GENE-13. GENOMIC FUNCTIONAL ENHANCERS DEFINE POTENTIAL TUMORIGENESIS OF G-CIMP-LOW (IDH-MUTANT ASTROCYTOMA) TUMORS INDEPENDENT OF PROMOTER METHYLATION Neuro-Oncology. 20: vi105-vi105. DOI: 10.1093/Neuonc/Noy148.439 |
0.462 |
|
2018 |
Malta T, Snyder J, deCarvalho A, Poisson L, Souza C, Zadeh G, Aldape K, Tirapelli D, Carlotti C, Lee I, Kalkanis S, Walbert T, Noushmehr H. GENE-09. FUNCTIONAL GENOMIC ELEMENTS DEFINED BY DNA METHYLATION CAN DISTINGUISH MENINGIOMA SUBGROUPS Neuro-Oncology. 20: vi104-vi104. DOI: 10.1093/Neuonc/Noy148.436 |
0.427 |
|
2018 |
Mosella M, Malta T, Sabedot T, Felicella M, Aho T, Poisson L, deCarvalho A, Snyder J, Lee I, Kalkanis S, Walbert T, Noushmehr H, Rock J, Castro AV. GENE-07. GENOMIC ENHANCER METHYLATION IS ASSOCIATED WITH BIOLOGICAL AND CLINICAL FEATURES IN PITUITARY TUMORS Neuro-Oncology. 20: vi104-vi104. DOI: 10.1093/Neuonc/Noy148.434 |
0.458 |
|
2018 |
Larion M, Rodado VR, Seki T, Malta T, Lita A, Dowdy T, Celiku O, Saldana AC, Li A, Zhang W, Song H, Davis D, Lee S, Neckers J, Munasinghe J, ... Noushmehr H, et al. CBMT-42. LOSS OF PROMOTER METHYLATION IN GLYCOLYTIC GENES IS ASSOCIATED WITH AGGRESSIVENESS IN IDH1-MUTANT LOWER GRADE GLIOMAS Neuro-Oncology. 20: vi41-vi42. DOI: 10.1093/Neuonc/Noy148.161 |
0.401 |
|
2018 |
Irtenkauf S, Hasselbach L, Transou A, Poisson L, Noushmehr H, Rybkin I, deCarvalho A. TMOD-06. HIGH INCIDENCE OF TUMORS AFTER TREATMENT WITH A DNA-ALKYLATING AGENT IN MOUSE STRAINS COMMONLY USED IN PRE-CLINICAL STUDIES Neuro-Oncology. 20: vi269-vi269. DOI: 10.1093/Neuonc/Noy148.1119 |
0.35 |
|
2017 |
Meliso FM, Micali D, Silva CT, Sabedot TS, Coetzee SG, Koch A, Fahlbusch FB, Noushmehr H, Schneider-Stock R, Jasiulionis MG. SIRT1 regulates Mxd1 during malignant melanoma progression. Oncotarget. 8: 114540-114553. PMID 29383100 DOI: 10.18632/Oncotarget.21457 |
0.388 |
|
2017 |
Malta TM, de Souza CF, Sabedot TS, Silva TC, Mosella MQS, Kalkanis SN, Snyder J, Castro AVB, Noushmehr H. Glioma CpG Island Methylator Phenotype (G-CIMP): Biological and Clinical Implications. Neuro-Oncology. PMID 29036500 DOI: 10.1093/Neuonc/Nox183 |
0.429 |
|
2017 |
Mazor T, Chesnelong C, Pankov A, Jalbert LE, Hong C, Hayes J, Smirnov IV, Marshall R, Souza CF, Shen Y, Viswanath P, Noushmehr H, Ronen SM, Jones SJM, Marra MA, et al. Clonal expansion and epigenetic reprogramming following deletion or amplification of mutant IDH1. Proceedings of the National Academy of Sciences of the United States of America. PMID 28916733 DOI: 10.1073/Pnas.1708914114 |
0.392 |
|
2017 |
Malta T, Sokolov A, Gentles AJ, Burzykowski T, Gevaert O, Laird PW, Noushmehr H, Wiznerowicz M. Abstract LB-004: Molecular hallmarks of cancer: Stemness Cancer Research. 77. DOI: 10.1158/1538-7445.Am2017-Lb-004 |
0.532 |
|
2017 |
Mosella M, Sarraf T, Malta T, Chedraoui T, Noushmehr H, Castro AV. GENE-52. EPIGENOMIC GLIOMA SUBTYPE EVALUATION ACROSS 31 TUMOR TYPES Neuro-Oncology. 19: vi103-vi104. DOI: 10.1093/Neuonc/Nox168.424 |
0.384 |
|
2017 |
Souza C, Noushmehr H. GENE-26. PREDICTIVE SIGNATURE OF MALIGNANT RECURRENCE IN G-CIMP TUMORS Neuro-Oncology. 19: vi98-vi98. DOI: 10.1093/Neuonc/Nox168.400 |
0.368 |
|
2016 |
Silva TC, Colaprico A, Olsen C, D'Angelo F, Bontempi G, Ceccarelli M, Noushmehr H. TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages. F1000research. 5: 1542. PMID 28232861 DOI: 10.12688/F1000Research.8923.2 |
0.442 |
|
2016 |
Ceccarelli M, Barthel FP, Malta TM, Sabedot TS, Salama SR, Murray BA, Morozova O, Newton Y, Radenbaugh A, Pagnotta SM, Anjum S, Wang J, Manyam G, Zoppoli P, Ling S, ... ... Noushmehr H, et al. Molecular Profiling Reveals Biologically Discrete Subsets and Pathways of Progression in Diffuse Glioma. Cell. 164: 550-563. PMID 26824661 DOI: 10.1016/J.Cell.2015.12.028 |
0.613 |
|
2016 |
Mota JM, Leite CA, Souza LE, Melo PH, Nascimento DC, de Deus Wagatsuma VM, Temporal J, Figueiredo F, Noushmehr H, Alves-Filho JC, Cunha FQ, Rego EM. Post-sepsis state induces tumor-associated macrophage accumulation through CXCR4/CXCL12 and favors tumor progression in mice. Cancer Immunology Research. PMID 26817997 DOI: 10.1158/2326-6066.Cir-15-0170 |
0.341 |
|
2016 |
Silva TTC, Colaprico A, Olsen C, D'Angelo F, Bontempi G, Ceccarelli M, Noushmehr H. TCGA Workflow: Analyze cancer genomics and epigenomics data using Bioconductor packages [version 1; referees: 1 approved, 1 approved with reservations] F1000research. 5: 1542. DOI: 10.12688/F1000Research.8923.1 |
0.373 |
|
2016 |
Stetson LC, Souza CFd, Malta TM, Sabedot TS, Ostrom Q, Liao P, Tirapelli DPdC, Neder L, Carlotti CG, Akbani R, Salama S, Poisson L, Brat D, Noushmehr H, Barnholtz-Sloan J. Abstract 780: Multi-omic profiling of gliomas reveals distinct DNA methylation changes at tumor recurrence Cancer Research. 76: 780-780. DOI: 10.1158/1538-7445.Am2016-780 |
0.528 |
|
2016 |
Malta T, Wiznerowicz M, Noushmehr H. GENT-34. EPIGENOMIC STEMNESS SIGNATURE ASSOCIATED WITH GLIOMA MOLECULAR SUBTYPES Neuro-Oncology. 18: vi81-vi81. DOI: 10.1093/Neuonc/Now212.340 |
0.313 |
|
2016 |
Sabedot TS, Malta T, Ceccarelli M, Dihn H, Berman B, Noushmehr H. GENT-33. EPIGENETIC ALTERATIONS AT INTERGENIC REGIONS ASSOCIATED WITH PROGRESSION IN A SUBSET OF IDH MUTANT GLIOMAS Neuro-Oncology. 18: vi81-vi81. DOI: 10.1093/Neuonc/Now212.339 |
0.359 |
|
2015 |
Colaprico A, Silva TC, Olsen C, Garofano L, Cava C, Garolini D, Sabedot TS, Malta TM, Pagnotta SM, Castiglioni I, Ceccarelli M, Bontempi G, Noushmehr H. TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Research. PMID 26704973 DOI: 10.1093/Nar/Gkv1507 |
0.435 |
|
2015 |
Brat DJ, Verhaak RG, Aldape KD, Yung WK, Salama SR, Cooper LA, Rheinbay E, Miller CR, Vitucci M, Morozova O, Robertson AG, Noushmehr H, Laird PW, Cherniack AD, et al. Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. The New England Journal of Medicine. 372: 2481-98. PMID 26061751 DOI: 10.1056/Nejmoa1402121 |
0.703 |
|
2015 |
Coetzee SG, Shen HC, Hazelett DJ, Lawrenson K, Kuchenbaecker K, Tyrer J, Rhie SK, Levanon K, Karst A, Drapkin R, Ramus SJ, Couch FJ, Offit K, Chenevix-Trench G, ... ... Noushmehr H, et al. Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. Human Molecular Genetics. 24: 3595-607. PMID 25804953 DOI: 10.1093/Hmg/Ddv101 |
0.412 |
|
2015 |
Segundo Correia Mota JM, Leite CA, Sousa LE, Wagatsuma VM, Noushmehr H, Cunha FQ, Rego EM. Effect of tumor-associated macrophages on neoplastic progression in sepsis-surviving mice through CXCL12/CXCR4. Journal of Clinical Oncology. 33: e22107-e22107. DOI: 10.1200/Jco.2015.33.15_Suppl.E22107 |
0.32 |
|
2015 |
Meliso FM, Silva CTd, Coetzee S, Sabedot TS, Noushmehr H, Schneider-Stock R, Jasiulionis MG. Abstract 4767: DNA sequences differentially associated with Sirt1 and Dnmt3b during melanoma progression Cancer Research. 75: 4767-4767. DOI: 10.1158/1538-7445.Am2015-4767 |
0.448 |
|
2015 |
Barthel FP, Ceccarelli M, Malta TM, Sabedot TS, Salama SR, Pagnotta SM, Murray BA, Morozova O, Newton Y, Brat DJ, Cherniack AD, Zhang H, Poisson L, Cooper L, Rabadan R, ... ... Noushmehr H, et al. GENO-06A PAN-GLIOMA CHARACTERIZATION OF GENOMIC, EPIGENOMIC AND TRANSCRIPTOMIC ACTIVITIES REVEALS NOVEL RELATIONSHIPS BETWEEN HISTOLOGICAL SUBTYPES AND MOLECULAR SIGNATURES Neuro-Oncology. 17: v92.2-v92. DOI: 10.1093/Neuonc/Nov215.06 |
0.633 |
|
2015 |
Souza C, Malta T, Sabedot T, Stetson L, Tirapelli D, Neder L, Carlotti C, ZenKlusen J, Salama S, Poisson L, Brat D, Barnholtz-Sloan J, Noushmehr H. Epig-16Most Differential Dna Methylation Changes Occur At Candidate Enhancer Elements For Recurrent Lower Grade Glioma And Glioblastoma Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov214.16 |
0.462 |
|
2015 |
Malta T, Sabedot T, Ceccarelli M, Barthel F, Pagnotta S, Iavarone A, Verhaak R, Noushmehr H. EPIG-14EPIGENOMIC (DNA METHYLATION AND EXPRESSION) SIGNATURES DEFINE SUBSETS OF BOTH IDHmut AND IDHwt GLIOMA WITH DISTINCT CLINICAL OUTCOMES Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov214.14 |
0.464 |
|
2014 |
Lawrenson K, Lee N, Torres HA, Lee JM, Brueggmann D, Rao PN, Noushmehr H, Gayther SA. Src as a novel therapeutic target for endometriosis. Gynecologic Oncology. 135: 100-7. PMID 24972189 DOI: 10.1016/J.Ygyno.2014.06.016 |
0.356 |
|
2014 |
Rhie SK, Hazelett DJ, Coetzee SG, Yan C, Noushmehr H, Coetzee GA. Nucleosome positioning and histone modifications define relationships between regulatory elements and nearby gene expression in breast epithelial cells. Bmc Genomics. 15: 331. PMID 24885402 DOI: 10.1186/1471-2164-15-331 |
0.357 |
|
2014 |
Hazelett DJ, Rhie SK, Gaddis M, Yan C, Lakeland DL, Coetzee SG, Henderson BE, Noushmehr H, Cozen W, Kote-Jarai Z, Eeles RA, Easton DF, Haiman CA, et al. Comprehensive functional annotation of 77 prostate cancer risk loci. Plos Genetics. 10: e1004102. PMID 24497837 DOI: 10.1371/Journal.Pgen.1004102 |
0.332 |
|
2014 |
Biancolella M, Fortini BK, Tring S, Plummer SJ, Mendoza-Fandino GA, Hartiala J, Hitchler MJ, Yan C, Schumacher FR, Conti DV, Edlund CK, Noushmehr H, Coetzee SG, Bresalier RS, Ahnen DJ, et al. Identification and characterization of functional risk variants for colorectal cancer mapping to chromosome 11q23.1. Human Molecular Genetics. 23: 2198-209. PMID 24256810 DOI: 10.1093/Hmg/Ddt584 |
0.303 |
|
2014 |
Shen HC, Coetzee S, Hazelett DJ, Coetzee GA, Noushmehr H, Gayther SA. Abstract 1380: Genome-wide fingerprinting of regulatory chromatin to evaluate the tissue specific origins of high-grade serous ovarian cancer Cancer Research. 74: 1380-1380. DOI: 10.1158/1538-7445.Am2014-1380 |
0.433 |
|
2014 |
Brennan C, Verhaak R, McKenna A, Campos B, Noushmehr H, Salama S, Zheng S, Chakravarty D, Sanborn J, Berman S, Beroukhim R, Bernard B, Wu C, Genovese G, Shmulevich I, et al. The Somatic Genomic Landscape of Glioblastoma Cell. 157: 753. DOI: 10.1016/J.Cell.2014.04.004 |
0.542 |
|
2013 |
Brennan CW, Verhaak RG, McKenna A, Campos B, Noushmehr H, Salama SR, Zheng S, Chakravarty D, Sanborn JZ, Berman SH, Beroukhim R, Bernard B, Wu CJ, Genovese G, Shmulevich I, et al. The somatic genomic landscape of glioblastoma. Cell. 155: 462-77. PMID 24120142 DOI: 10.1016/J.Cell.2013.09.034 |
0.64 |
|
2013 |
Rhie SK, Coetzee SG, Noushmehr H, Yan C, Kim JM, Haiman CA, Coetzee GA. Comprehensive functional annotation of seventy-one breast cancer risk Loci. Plos One. 8: e63925. PMID 23717510 DOI: 10.1371/Journal.Pone.0063925 |
0.311 |
|
2013 |
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, ... ... Noushmehr H, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 45: 362-70, 370e1-2. PMID 23535730 DOI: 10.1038/Ng.2564 |
0.38 |
|
2013 |
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, ... ... Noushmehr H, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications. 4: 1627. PMID 23535648 DOI: 10.1038/Ncomms2613 |
0.348 |
|
2012 |
Coetzee SG, Rhie SK, Berman BP, Coetzee GA, Noushmehr H. FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs. Nucleic Acids Research. 40: e139. PMID 22684628 DOI: 10.1093/Nar/Gks542 |
0.327 |
|
2012 |
Yang X, Noushmehr H, Han H, Andreu-Vieyra C, Liang G, Jones PA. Gene reactivation by 5-aza-2'-deoxycytidine-induced demethylation requires SRCAP-mediated H2A.Z insertion to establish nucleosome depleted regions. Plos Genetics. 8: e1002604. PMID 22479200 DOI: 10.1371/Journal.Pgen.1002604 |
0.411 |
|
2012 |
Little GH, Noushmehr H, Baniwal SK, Berman BP, Coetzee GA, Frenkel B. Genome-wide Runx2 occupancy in prostate cancer cells suggests a role in regulating secretion. Nucleic Acids Research. 40: 3538-47. PMID 22187159 DOI: 10.1093/Nar/Gkr1219 |
0.389 |
|
2012 |
Berman BP, Weisenberger DJ, Aman JF, Hinoue T, Ramjan Z, Liu Y, Noushmehr H, Lange CP, van Dijk CM, Tollenaar RA, Van Den Berg D, Laird PW. Regions of focal DNA hypermethylation and long-range hypomethylation in colorectal cancer coincide with nuclear lamina-associated domains. Nature Genetics. 44: 40-6. PMID 22120008 DOI: 10.1038/Ng.969 |
0.766 |
|
2012 |
Hinoue T, Weisenberger DJ, Lange CP, Shen H, Byun HM, Van Den Berg D, Malik S, Pan F, Noushmehr H, van Dijk CM, Tollenaar RA, Laird PW. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Research. 22: 271-82. PMID 21659424 DOI: 10.1101/gr.117523.110 |
0.74 |
|
2012 |
Berman BP, Weisenberger DJ, Hinoue T, Noushmehr H, Liu Y, Aman JF, Hinoue T, Shen H, Malik S, Mahurkar S, Triche T, Ramjan Z, Nicolet CM, Van Den Berg D, Cope L, et al. Exploring the cancer methylome Bmc Proceedings. 6. DOI: 10.1186/1753-6561-6-S6-O24 |
0.777 |
|
2012 |
Noushmehr H, Coetzee SG, Rhie SK, Yan C, Haiman CA, Berman BP, Frenkel B, Coetzee GA. Abstract 1646: Integrative analysis identifies functional prostate cancer risk SNPs in genomic regulatory regions defined as enhancers Cancer Research. 72: 1646-1646. DOI: 10.1158/1538-7445.Am2012-1646 |
0.372 |
|
2011 |
Hinoue T, Weisenberger DJ, Lange CPE, Noushmehr H, Byun H, Dijk CMv, Pan F, Malik S, Berg DJVD, Shen H, Tollenaar RAEM, Laird PW. Abstract LB-173: Genome-scale analysis of aberrant DNA methylation in colorectal cancer Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-173 |
0.757 |
|
2010 |
Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, Berman BP, Pan F, Pelloski CE, Sulman EP, Bhat KP, Verhaak RG, Hoadley KA, Hayes DN, Perou CM, Schmidt HK, et al. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell. 17: 510-22. PMID 20399149 DOI: 10.1016/J.Ccr.2010.03.017 |
0.64 |
|
2010 |
Teschendorff AE, Menon U, Gentry-Maharaj A, Ramus SJ, Weisenberger DJ, Shen H, Campan M, Noushmehr H, Bell CG, Maxwell AP, Savage DA, Mueller-Holzner E, Marth C, Kocjan G, Gayther SA, et al. Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Research. 20: 440-6. PMID 20219944 DOI: 10.1101/Gr.103606.109 |
0.6 |
|
2008 |
Brown JL, Snir M, Noushmehr H, Kirby M, Hong SK, Elkahloun AG, Feldman B. Transcriptional profiling of endogenous germ layer precursor cells identifies dusp4 as an essential gene in zebrafish endoderm specification. Proceedings of the National Academy of Sciences of the United States of America. 105: 12337-42. PMID 18719100 DOI: 10.1073/Pnas.0805589105 |
0.351 |
|
2007 |
Pei W, Noushmehr H, Costa J, Ouspenskaia MV, Elkahloun AG, Feldman B. An early requirement for maternal FoxH1 during zebrafish gastrulation. Developmental Biology. 310: 10-22. PMID 17719025 DOI: 10.1016/J.Ydbio.2007.07.011 |
0.312 |
|
Low-probability matches (unlikely to be authored by this person) |
2023 |
Bredel M, Espinosa L, Kim H, Scholtens DM, McElroy JP, Rajbhandari R, Meng W, Kollmeyer TM, Malta TM, Quezada MA, Harsh GR, Lobo-Jarne T, Solé L, Merati A, Nagaraja S, ... ... Noushmehr H, et al. Haploinsufficiency of NFKBIA reshapes the epigenome antipodal to the IDH mutation and imparts disease fate in diffuse gliomas. Cell Reports. Medicine. 4: 101082. PMID 37343523 DOI: 10.1016/j.xcrm.2023.101082 |
0.298 |
|
2019 |
Malta T, Sabedot T, Lee I, Wells M, Castro A, Noushmehr H. OS8.8 Modified chromatin histone marks at noncoding elements are associated with aggressive meningioma subtype Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz126.058 |
0.292 |
|
2017 |
Lawrenson K, Abraao M, Segato F, Lee JM, Coetzee S, Seo J, Freedman ML, Hazelett D, Gayther S, Noushmehr H. Abstract 2417: Large scale integrated transcriptomic and epigenetic profiling defines the molecular hallmarks of HGSOC and disease origins Cancer Research. 77: 2417-2417. DOI: 10.1158/1538-7445.Am2017-2417 |
0.291 |
|
2018 |
Silva TC, Colaprico A, Olsen C, Malta TM, Bontempi G, Ceccarelli M, Berman BP, Noushmehr H. TCGAbiolinksGUI: A graphical user interface to analyze cancer molecular and clinical data F1000research. 7: 439. DOI: 10.12688/F1000Research.14197.1 |
0.287 |
|
2020 |
Golebiewska A, Hau AC, Oudin A, Stieber D, Yabo YA, Baus V, Barthelemy V, Klein E, Bougnaud S, Keunen O, Wantz M, Michelucci A, Neirinckx V, Muller A, Kaoma T, ... ... Noushmehr H, et al. Patient-derived organoids and orthotopic xenografts of primary and recurrent gliomas represent relevant patient avatars for precision oncology. Acta Neuropathologica. PMID 33009951 DOI: 10.1007/s00401-020-02226-7 |
0.286 |
|
2019 |
Thorsson V, Gibbs DL, Brown SD, Wolf D, Bortone DS, Ou Yang TH, Porta-Pardo E, Gao GF, Plaisier CL, Eddy JA, Ziv E, Culhane AC, Paull EO, Sivakumar IKA, Gentles AJ, ... ... Noushmehr H, et al. The Immune Landscape of Cancer. Immunity. 51: 411-412. PMID 31433971 DOI: 10.1016/J.Immuni.2019.08.004 |
0.284 |
|
2017 |
Kaneto CM, Pereira Lima PS, Prata KL, Dos Santos JL, de Pina Neto JM, Panepucci RA, Noushmehr H, Covas DT, de Paula FJ, Silva WA. Gene expression profiling of bone marrow mesenchymal stem cells from Osteogenesis Imperfecta patients during osteoblast differentiation. European Journal of Medical Genetics. PMID 28396251 DOI: 10.1016/J.Ejmg.2017.04.003 |
0.282 |
|
2019 |
Malta T, Sabedot TS, jr CC, Noushmehr H. Gene-58. Active Transcription Start Sites Of Meningioma Samples Associated With Risk Of Recurrence Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.460 |
0.282 |
|
2018 |
Verhaak R, Consortium G, Aldape K, Amin S, Ashley D, Barnholtz-Sloan J, Bates A, Beroukhim R, Bock C, Brat D, Claus E, Costello J, de Groot J, Finocchiaro G, French P, ... ... Noushmehr H, et al. DRES-05. MOLECULAR EVOLUTION OF DIFFUSE GLIOMAS AND THE GLIOMA LONGITUDINAL ANALYSIS CONSORTIUM Neuro-Oncology. 20: vi76-vi76. DOI: 10.1093/Neuonc/Noy148.312 |
0.282 |
|
2023 |
Malta TM, Snyder J, Noushmehr H, Castro AV. Advances in Central Nervous System Tumor Classification. Advances in Experimental Medicine and Biology. 1416: 121-135. PMID 37432624 DOI: 10.1007/978-3-031-29750-2_10 |
0.278 |
|
2006 |
Feldman B, Boorech JL, Noushmehr H, Kirby M, Elkahloun AG. FACS-assisted microdissection of photolabeled cells to identify germ layer-specific genes Developmental Biology. 295: 412-413. DOI: 10.1016/J.Ydbio.2006.04.267 |
0.277 |
|
2021 |
Wong QH, Li KK, Wang WW, Malta TM, Noushmehr H, Grabovska Y, Jones C, Chan AK, Kwan JS, Huang QJ, Wong GC, Li WC, Liu XZ, Chen H, Chan DT, et al. Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 33692446 DOI: 10.1038/s41379-021-00778-x |
0.276 |
|
2017 |
Sabedot TS, Poisson L, deCarvalho AC, Noushmehr H. GENE-56. DEPLETION OF 5-HYDROXYMETHYLCYTOSINE IN AGGRESSIVE G-CIMP SUBTYPE Neuro-Oncology. 19: vi105-vi105. DOI: 10.1093/Neuonc/Nox168.428 |
0.275 |
|
2023 |
Herrgott GA, Snyder JM, She R, Malta TM, Sabedot TS, Lee IY, Pawloski J, Podolsky-Gondim GG, Asmaro KP, Zhang J, Cannella CE, Nelson K, Thomas B, deCarvalho AC, Hasselbach LA, ... ... Noushmehr H, et al. Detection of diagnostic and prognostic methylation-based signatures in liquid biopsy specimens from patients with meningiomas. Nature Communications. 14: 5669. PMID 37704607 DOI: 10.1038/s41467-023-41434-z |
0.272 |
|
2019 |
Gu S, Zaidi S, Hassan MI, Mohammad T, Malta TM, Noushmehr H, Nguyen B, Crandall KA, Srivastav J, Obias V, Lin P, Nguyen BN, Yao M, Yao R, King CH, et al. Mutated CEACAMs Disrupt Transforming Growth Factor beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis. Gastroenterology. PMID 31585122 DOI: 10.1053/J.Gastro.2019.09.023 |
0.271 |
|
2015 |
Coetzee S, Sabedot T, Silva TC, Coetzee G, Noushmehr H. Funci{SNP}: integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs biOMICs+: easily integrate public “OMICS” data for functional study F1000research. 4. DOI: 10.7490/F1000Research.1110817.1 |
0.269 |
|
2018 |
Garcia-Rosa S, Trivella DB, Marques VD, Serafim RB, Pereira JG, Lorenzi JC, Molfetta GA, Christo PP, Olival GS, Marchitto VB, Brum DG, Sabedot TS, Noushmehr H, Farias AS, Santos LM, et al. A non-functional galanin receptor-2 in a multiple sclerosis patient. The Pharmacogenomics Journal. PMID 30131588 DOI: 10.1038/S41397-018-0032-6 |
0.267 |
|
2015 |
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Noushmehr H, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 |
0.264 |
|
2017 |
Meliso FM, Micali D, Silva CT, Sabedot TS, Coetzee SG, Koch A, Fahlbusch FB, Noushmehr H, Schneider-Stock R, Jasiulionis MG. Abstract 2413: SIRT1 regulatesMxd1throughout melanoma progression Cancer Research. 77: 2413-2413. DOI: 10.1158/1538-7445.Am2017-2413 |
0.262 |
|
2022 |
Liu EM, Shi ZF, Li KK, Malta TM, Chung NY, Chen H, Chan JY, Poon MF, Kwan JS, Chan DT, Noushmehr H, Mao Y, Ng HK. Molecular landscape of IDH-wild type, pTERT-wild type adult glioblastomas. Brain Pathology (Zurich, Switzerland). e13107. PMID 35815721 DOI: 10.1111/bpa.13107 |
0.252 |
|
2007 |
Feldman B, Brown JL, Noushmehr H, Kirby M, Elkahloun AG. FACS-assisted microdissection of early zebrafish embryos for transcriptional profiling and cell behavioral studies Developmental Biology. 306: 410. DOI: 10.1016/J.Ydbio.2007.03.631 |
0.25 |
|
2017 |
Malta T, Snyder J, Kalkanis S, Castro AV, Noushmehr H. IMMU-60. PD-L1 EXPRESSION ASSOCIATED WITH GLIOMA MOLECULAR SUBTYPES: CLINICAL IMPLICATIONS Neuro-Oncology. 19: vi126-vi126. DOI: 10.1093/Neuonc/Nox168.518 |
0.249 |
|
2017 |
Cava C, Colaprico A, Bertoli G, Graudenzi A, Silva TC, Olsen C, Noushmehr H, Bontempi G, Mauri G, Castiglioni I. SpidermiR: An R/Bioconductor Package for Integrative Analysis with miRNA Data. International Journal of Molecular Sciences. 18. PMID 28134831 DOI: 10.3390/Ijms18020274 |
0.246 |
|
2021 |
Tesileanu CMS, van den Bent MJ, Sanson M, Wick W, Brandes AA, Clement PM, Erridge SC, Vogelbaum MA, Nowak AK, Baurain JF, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, ... ... Noushmehr H, et al. Prognostic significance of genome-wide DNA methylation profiles within the randomised, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-Oncology. PMID 33914057 DOI: 10.1093/neuonc/noab088 |
0.241 |
|
2022 |
Noushmehr H, Herrgott G, Morosini NS, Castro AV. Noninvasive approaches to detect methylation-based markers to monitor gliomas. Neuro-Oncology Advances. 4: ii22-ii32. PMID 36380867 DOI: 10.1093/noajnl/vdac021 |
0.24 |
|
2018 |
Lee I, Scarpace L, Nelson K, Patil D, Datta V, Akolkar D, Apurva S, Fulmali P, Puranik S, Snyder J, Noushmehr H, Devhare P, deCarvalho A, Datar R, Walbert T, et al. PATH-37. LIQUID BIOPSY FOR IDENTIFICATION OF NEWLY DIAGNOSED GLIOMA Neuro-Oncology. 20: vi166-vi167. DOI: 10.1093/Neuonc/Noy148.693 |
0.24 |
|
2012 |
Noushmehr H, Coetzee SG, Rhie SK, Yan C, Coetzee GA. The functionality of prostate cancer predisposition risk regions is revealed by AR enhancers Androgen-Responsive Genes in Prostate Cancer: Regulation, Function and Clinical Applications. 59-84. DOI: 10.1007/978-1-4614-6182-1_5 |
0.239 |
|
2011 |
Noushmehr H, Coetzee GA. Identification and functional annotation of GWAS risk SNPs. Cell Cycle (Georgetown, Tex.). 10: 3995-6. PMID 22101276 DOI: 10.4161/Cc.10.23.18237 |
0.238 |
|
2019 |
Lee I, Scarpace L, Hunt R, Nelson K, Patil D, Datta V, Akolkar D, Apurva S, Fulmali P, Puranik S, Snyder J, Noushmehr H, Devhare P, deCarvalho A, Datar R, et al. Path-64. Prospective, Blinded Plasma Based Analysis For Diagnosis Of Newly Diagnosed Glioma Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.659 |
0.229 |
|
2019 |
Snyder J, Wells M, Poisson L, Kalkanis S, Noushmehr H, Robin A. Innv-15. Clinical Data That Matters: A Distillation Of Neuro-Oncology Clinical Trial Inclusion Criteria Using Machine Learning Neuro-Oncology. 21. DOI: 10.1093/Neuonc/Noz175.558 |
0.216 |
|
2005 |
Noushmehr H, D'Amico E, Farilla L, Hui H, Wawrowsky KA, Mlynarski W, Doria A, Abumrad NA, Perfetti R. Fatty acid translocase (FAT/CD36) is localized on insulin-containing granules in human pancreatic beta-cells and mediates fatty acid effects on insulin secretion. Diabetes. 54: 472-81. PMID 15677505 DOI: 10.2337/Diabetes.54.2.472 |
0.21 |
|
2003 |
Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R. Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology. 144: 5149-58. PMID 12960095 DOI: 10.1210/En.2003-0323 |
0.209 |
|
2018 |
Prendergast EN, de Souza Fonseca MA, Dezem FS, Lester J, Karlan BY, Noushmehr H, Lin X, Lawrenson K. Optimizing exosomal RNA isolation for RNA-Seq analyses of archival sera specimens. Plos One. 13: e0196913. PMID 29738525 DOI: 10.1371/Journal.Pone.0196913 |
0.209 |
|
2021 |
Datta I, Noushmehr H, Brodie C, Poisson LM. Expression and regulatory roles of lncRNAs in G-CIMP-low vs G-CIMP-high Glioma: an in-silico analysis. Journal of Translational Medicine. 19: 182. PMID 33926464 DOI: 10.1186/s12967-021-02844-z |
0.202 |
|
2015 |
Tiezzi D, Noushmehr H, Silveira W, Sabedot T, Andrade J. Germ cells and mammary gland transcritome comparison generate a powerful gene expression profile that predicts breast cancer survival Annals of Oncology. 26: iii10. DOI: 10.1093/annonc/mdv116.06 |
0.188 |
|
2021 |
Reddy J, Fonseca MAS, Corona RI, Nameki R, Segato Dezem F, Klein IA, Chang H, Chaves-Moreira D, Afeyan LK, Malta TM, Lin X, Abbasi F, Font-Tello A, Sabedot T, Cejas P, ... ... Noushmehr H, et al. Predicting master transcription factors from pan-cancer expression data. Science Advances. 7: eabf6123. PMID 34818047 DOI: 10.1126/sciadv.abf6123 |
0.183 |
|
2019 |
Li KK, Shi ZF, Malta TM, Chan AK, Cheng S, Kwan JSH, Yang RR, Poon WS, Mao Y, Noushmehr H, Chen H, Ng HK. Identification of subsets of -mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks. Neuro-Oncology Advances. 1: vdz015. PMID 31667475 DOI: 10.1093/noajnl/vdz015 |
0.159 |
|
2021 |
Wong QH, Li KK, Wang WW, Malta TM, Noushmehr H, Grabovska Y, Jones C, Chan AK, Kwan JS, Huang QJ, Wong GC, Li WC, Liu XZ, Chen H, Chan DT, et al. Correction to: Molecular landscape of IDH-mutant primary astrocytoma Grade IV/Glioblastomas. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 33859362 DOI: 10.1038/s41379-021-00802-0 |
0.143 |
|
2021 |
Danko D, Bezdan D, Afshin EE, Ahsanuddin S, Bhattacharya C, Butler DJ, Chng KR, Donnellan D, Hecht J, Jackson K, Kuchin K, Karasikov M, Lyons A, Mak L, Meleshko D, ... ... Noushmehr H, et al. A global metagenomic map of urban microbiomes and antimicrobial resistance. Cell. PMID 34043940 DOI: 10.1016/j.cell.2021.05.002 |
0.138 |
|
2023 |
Kocakavuk E, Johnson KC, Sabedot TS, Reinhardt HC, Noushmehr H, Verhaak RGW. Hemizygous CDKN2A deletion confers worse survival outcomes in IDHmut-noncodel gliomas. Neuro-Oncology. PMID 37329568 DOI: 10.1093/neuonc/noad095 |
0.089 |
|
2020 |
Chaudhry F, Hunt RJ, Hariharan P, Anand SK, Sanjay S, Kjoller EE, Bartlett CM, Johnson KW, Levy PD, Noushmehr H, Lee IY. Machine Learning Applications in the Neuro ICU: A Solution to Big Data Mayhem? Frontiers in Neurology. 11: 554633. PMID 33162926 DOI: 10.3389/fneur.2020.554633 |
0.066 |
|
2022 |
Short SC, Noushmehr H. Unmet need for liquid biomarkers and the Brain-Liquid Biopsy Consortium. Neuro-Oncology Advances. 4: ii1-ii3. PMID 36380869 DOI: 10.1093/noajnl/vdac020 |
0.051 |
|
2022 |
Robin AM, Pawloski JA, Snyder JM, Walbert T, Rogers L, Mikkelsen T, Noushmehr H, Lee I, Rock J, Kalkanis SN, Rosenblum ML. Neurosurgery's Impact on Neuro-Oncology-"Can We Do Better?"-Lessons Learned Over 50 Years. Neurosurgery. 68: 17-26. PMID 36069696 DOI: 10.1227/NEU.0000000000001879 |
0.03 |
|
Hide low-probability matches. |